Latest Close
$2.08
News
ADIL
Adial Pharmaceuticals, Inc News
This news view pulls recent coverage and headlines tied to ADIL.
1y Change
-$15.17 (-87.94%)
Market Cap
$4,458,731.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update
GlobeNewswire • May 11, 2026
Read articleAdial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045
GlobeNewswire • Apr 29, 2026
Read articleAdial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program
GlobeNewswire • Apr 27, 2026
Read articleAdial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial
GlobeNewswire • Apr 22, 2026
Read articleAdial Pharmaceuticals Commends Congress on Introduction of Bipartisan Legislation Expanding Access to Emerging AUD Therapies for Veterans
GlobeNewswire • Mar 24, 2026
Read articleAdial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
GlobeNewswire • Mar 6, 2026
Read article